1 – 92 of 92
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
(
- Contribution to journal › Article
-
Mark
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
(
- Contribution to journal › Article
- 2023
-
Mark
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
2023) In Journal of Translational Medicine(
- Contribution to journal › Article
-
Mark
Abstract 5710: Detection and monitoring of t(11;14) in liquid biopsies from patients with relapsed/refractory multiple myeloma treated with venetoclax-based regimens
(
- Contribution to journal › Published meeting abstract
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
-
Mark
Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
(
- Contribution to journal › Article
-
Mark
Functional In Vivo Screening Identifies microRNAs Regulating Metastatic Dissemination of Prostate Cancer Cells to Bone Marrow
(
- Contribution to journal › Article
-
Mark
Lung adenocarcinoma promotion by air pollutants
(
- Contribution to journal › Article
-
Mark
Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer
(
- Contribution to journal › Article
-
Mark
805P Tumor-informed ctDNA detection as a predictive marker for postoperative residual disease in epithelial ovarian cancer: A feasibility study
(
- Contribution to journal › Published meeting abstract
-
Mark
#898 Tumor-informed ctDNA detection as a marker for postoperative residual disease in epithelial ovarian cancer : results of a feasibility study
(
- Contribution to journal › Published meeting abstract
-
Mark
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
(
- Contribution to journal › Article
-
Mark
Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
-
Mark
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
(
- Contribution to journal › Article
-
Mark
Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors
(
- Contribution to journal › Article
-
Mark
Autoimmunity to selenoprotein P predicts breast cancer recurrence
(
- Contribution to journal › Article
- 2021
-
Mark
Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
2021) In International Journal of Laboratory Hematology(
- Contribution to journal › Article
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
(
- Contribution to journal › Article
-
Mark
Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18(
- Contribution to journal › Published meeting abstract
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
(
- Contribution to journal › Article
-
Mark
Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival
(
- Contribution to journal › Published meeting abstract
-
Mark
The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
(
- Contribution to journal › Article
-
Mark
Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
Subclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis
(
- Contribution to journal › Article
-
Mark
Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
(
- Contribution to journal › Published meeting abstract
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
(
- Contribution to journal › Article
-
Mark
The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome
2020)(
- Working paper/Preprint › Preprint in preprint archive
- 2019
-
Mark
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
(
- Contribution to journal › Article
-
Mark
Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence
(
- Contribution to journal › Article
-
Mark
Refinement of breast cancer molecular classification by miRNA expression profiles
(
- Contribution to journal › Article
-
Mark
Tumor Characteristics and Molecular Subtypes in Breast Cancer Screening with Digital Breast Tomosynthesis : The Malmö Breast Tomosynthesis Screening Trial
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
(
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
(
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
(
- Contribution to journal › Article
- 2018
-
Mark
Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study : experiences from re-contacting mutation carriers and relatives
(
- Contribution to journal › Article
-
Mark
Identification and use of personalized genomic markers for monitoring circulating tumor DNA
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Tumor PIK3CA genotype and prognosis in early-stage breast cancer : A pooled analysis of individual patient data
(
- Contribution to journal › Article
-
Mark
Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study
(
- Contribution to journal › Published meeting abstract
-
Mark
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
(
- Contribution to journal › Article
-
Mark
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
(
- Contribution to journal › Article
-
Mark
Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B
(
- Contribution to journal › Published meeting abstract
-
Mark
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
(
- Contribution to journal › Article
-
Mark
Breast cancer screening with tomosynthesis - Distribution of cancer subtypes in the Malmö Breast Tomosynthesis Screening Trial
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Myoepithelium assessment with p63 immunostaining in formalinfixed paraffin-embedded breast cancer tissue pre-treated with RNA-later
(
- Contribution to journal › Published meeting abstract
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
-
Mark
Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)
(
- Contribution to journal › Published meeting abstract
-
Mark
p53 maintains baseline expression of multiple tumor suppressor genes
(
- Contribution to journal › Article
-
Mark
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
PTEN and NEDD4 in Human Breast Carcinoma.
(
- Contribution to journal › Article
-
Mark
Apparent exchange rate for breast cancer characterization.
(
- Contribution to journal › Article
-
Mark
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
(
- Contribution to journal › Article
-
Mark
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
(
- Contribution to journal › Article
-
Mark
TopHat-Recondition : A post-processor for TopHat unmapped reads
(
- Contribution to journal › Article
-
Mark
The state of the art in prediction of breast cancer relapse using cell-free circulating tumor DNA liquid biopsies
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
(
- Contribution to journal › Article
-
Mark
Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.
(
- Contribution to journal › Article
-
Mark
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.
(
- Contribution to journal › Article
-
Mark
Whole genome sequencing of primary breast cancers and matched distant metastases
2015) American Association for Cancer Research (AACR) 106th Annual Meeting 2015 In Cancer Research 75(15).(
- Contribution to journal › Published meeting abstract
-
Mark
Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
(
- Contribution to journal › Article
-
Mark
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.
(
- Contribution to journal › Article
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells
(
- Contribution to journal › Article
- 2012
-
Mark
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
(
- Contribution to journal › Article
-
Mark
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
- 2009
-
Mark
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma
(
- Contribution to journal › Article
-
Mark
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a
(
- Contribution to journal › Article
- 2008
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
(
- Contribution to journal › Article
-
Mark
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
(
- Contribution to journal › Article
- 2007
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
-
Mark
Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
(
- Contribution to journal › Article
-
Mark
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
(
- Contribution to journal › Article
- 2006
-
Mark
An introduction to BioArray software environment
(
- Contribution to journal › Scientific review
- 2005
-
Mark
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
(
- Contribution to journal › Article
-
Mark
Estrogen receptor (ER)-beta has favorable independent prognostic value for ER-alfa negative breast cancer patients receiving adjuvant tamoxifen
(
- Contribution to journal › Published meeting abstract
- 2002
-
Mark
Bioarray software environment: a platform for comprehensive management and analysis of microarray data
(
- Contribution to journal › Article
-
Mark
Gene expression profiling in cancer using cDNA microarrays
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2001
-
Mark
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
(
- Contribution to journal › Article
-
Mark
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
(
- Contribution to journal › Article
- 1999
-
Mark
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
(
- Contribution to journal › Article
-
Mark
Expression profiling in cancer using cDNA microarrays
(
- Contribution to journal › Scientific review